---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-077591"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2026-07-13T20:30:43+00:00"
generated_at: "2026-07-13T20:32:10.109497+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Apimeds Pharmaceuticals announces 1-for-10 reverse stock split effective July 24, 2026

## Summary
- Reverse stock split at 1-for-10 ratio, effective 12:01 a.m. ET on July 24, 2026.
- Stock will trade on NYSE American under symbol APUS on split-adjusted basis from July 24.
- New CUSIP number for post-split common stock is 03771D201.
- Previously expected effective date of March 26, 2026, was delayed; now set for July 24, 2026.
- Every ten pre-split shares will combine into one post-split share.

## SEC filing metadata
- accession: 0001213900-26-077591
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2026-07-13T20:30:43+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390026077591/0001213900-26-077591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390026077591/ea0297843-8k_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-077591
- JSON: https://secwatch.observer/filing/0001213900-26-077591.json
- Plain text: https://secwatch.observer/filing/0001213900-26-077591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.